The Community Option: The Road Less Traveled

Mary Kruczynski
Published: Sunday, Jul 08, 2018
Mary Kruczynski, director of policy analysis at COA

Mary Kruczynski
With the plethora of new targeted agents, immuno-oncologic therapeutics, and next-generation sequencing, there has never been a better time to be a hematologist/oncologist, as the armament is rich. That said, the army of physicians needed to do battle with cancer in the community setting is becoming a scarce commodity. Policy makers, healthcare organizations, providers, and payers are failing to recognize the value of the delivery of that care in the cancer patient’s community, close to home and a support system of family and friends.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication